One World Products, Inc. OWPC

FY2024 · ended Dec 31, 2024 · Revenue $4,863, -35.9% YoY · Filed Jun 3, 2025

One World Products, Inc. (OWPC) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2024, which ended Dec 31, 2024, it reported revenue of $4,863 and a net loss of $3.9 million.

Revenue (TTM)
$53,429
+1987.1% vs year-ago TTM
Net income (TTM)
$4.11M
+171.6% vs year-ago TTM
Operating cash flow (TTM)
$-705,206
+39.3% vs year-ago TTM
Free cash flow
$-1.20M
+15.8% vs prior year
EPS (TTM)
$0.03
+157.6% vs year-ago TTM
Dividend per share
$0.00
Shares outstanding
109.23M
+4.7% vs prior year
Net cash
$-416,899
FY 2022
Operating margin
-1930.5%
FY 2025

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OWPC (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Troy, MI
SEC filer status
, Emerging growth company
SEC CIK
1622244
Former names
One World Pharma, Inc. (until Nov 30, 2021); PUNTO GROUP, CORP. (until Jan 8, 2019)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Revenue
$4,863
$7,589
$125,662
$38,264
$59,568
Operating income
-$1.9M
-$2.1M
-$2.2M
-$3.2M
-$7.9M
Net income
-$3.9M
-$4.0M
-$3.1M
-$3.8M
-$8.0M
Diluted EPS
-$0.04
-$0.05
—
—
—
Operating cash flow
-$1.1M
-$1.2M
-$1.4M
-$3.7M
-$1.4M
Free cash flow
—
-$1.2M
-$1.4M
-$4.1M
-$1.5M
Total assets
$68,300
$98,882
$3.2M
$2.9M
$1.4M
Total liabilities
$5.3M
$3.9M
$4.2M
$1.7M
$1.9M
Stockholders' equity
-$9.9M
-$8.3M
-$5.8M
-$3.1M
-$2.0M
Cash and investments
$42,456
$726
$11,016
$119,678
$28,920
Total debt
—
—
$427,915
—
$201,525

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 27, 2026 Oct 27, 2026
8-K Current report
Officer or director change
Jul 27, 2026 Jul 23, 2026
8-K Current report
Officer or director change
Mar 27, 2026 Mar 27, 2026
10-Q Quarterly report Jan 2, 2026 Sep 30, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 21, 2025 Oct 21, 2025
8-K Current report
Officer or director change
Sep 30, 2025 Sep 29, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.